Insider Profile
Eyre, Sally Louise
3
Companies Filed At
0
Open-Market Buys (2yr)
Buy Value (2yr, open-market)
Jun 30, 2026
Most Recent Trade
Date Company Role Nature Dir. Shares Price Value Score
Jun 30, 2026 $ELD
Eldorado Gold Corporation
Comp. Grant Buy 473 60
Jun 16, 2026 $ELD
Eldorado Gold Corporation
Plan / DRIP Buy 4 60
Dec 10, 2025 $ERO
Ero Copper
Comp. Grant Buy 2,433 $34.58 $84K 38
Dec 10, 2025 $ERO
Ero Copper
Comp. Grant Buy 3,524 38
Nov 27, 2025 $ERO
Ero Copper
Exercise Sell 4,047 $20.73 38
Nov 27, 2025 $ERO
Ero Copper
Exercise Buy 4,047 $20.73 $84K 38
Mar 31, 2025 $ERO
Ero Copper
Comp. Grant Buy 940 38
Dec 31, 2024 $ERO
Ero Copper
Comp. Grant Buy 933 38
Dec 11, 2024 $ERO
Ero Copper
Comp. Grant Buy 6,016 38
Dec 11, 2024 $ERO
Ero Copper
Comp. Grant Buy 4,047 $20.73 $84K 38
May 31, 2024 $ERO
Ero Copper
Open Market Buy 10,580 38
May 31, 2024 $ERO
Ero Copper
Exercise Buy 6,208 $23.42 $145K 38
May 31, 2024 $ERO
Ero Copper
Exercise Sell 4,372 $18.04 $79K 38
May 31, 2024 $ERO
Ero Copper
Exercise Sell 6,208 $23.42 $145K 38
May 31, 2024 $ERO
Ero Copper
Exercise Buy 4,372 $18.04 $79K 38
Apr 01, 2024 $EQX
Equinox Gold
Other Buy 2,102 $7.64 $16K 63
Feb 06, 2024 $EQX
Equinox Gold
Comp. Grant Buy 17,011 $5.97 $102K 63
Jan 02, 2024 $EQX
Equinox Gold
Other Buy 2,217 $6.69 $15K 63
Dec 29, 2023 $ERO
Ero Copper
Comp. Grant Buy 754 38
Dec 13, 2023 $ERO
Ero Copper
Comp. Grant Buy 6,633 38
Dec 13, 2023 $ERO
Ero Copper
Comp. Grant Buy 4,372 $18.04 $79K 38
Oct 02, 2023 $EQX
Equinox Gold
Other Buy 2,666 $5.71 $15K 63
Sep 29, 2023 $ERO
Ero Copper
Comp. Grant Buy 727 38
Aug 11, 2023 $ERO
Ero Copper
Open Market Buy 8,177 38
Aug 11, 2023 $ERO
Ero Copper
Exercise Sell 4,040 $18.21 $74K 38
Aug 11, 2023 $ERO
Ero Copper
Exercise Sell 4,137 $18.69 $77K 38
Aug 11, 2023 $ERO
Ero Copper
Exercise Buy 4,040 $18.21 $74K 38
Aug 11, 2023 $ERO
Ero Copper
Exercise Buy 4,137 $18.69 $77K 38
Jul 04, 2023 $EQX
Equinox Gold
Other Buy 2,491 $5.97 $15K 63
Jun 30, 2023 $ERO
Ero Copper
Comp. Grant Buy 618 38
Apr 03, 2023 $EQX
Equinox Gold
Other Buy 2,189 $6.95 $15K 63
Mar 31, 2023 $ERO
Ero Copper
Comp. Grant Buy 705 38
Jan 20, 2023 $EQX
Equinox Gold
Exercise Buy 4,733 63
Jan 20, 2023 $EQX
Equinox Gold
Exercise Sell 4,733 63
Jan 16, 2023 $EQX
Equinox Gold
Exercise Buy 3,147 63
Jan 16, 2023 $EQX
Equinox Gold
Exercise Sell 3,147 63
Jan 12, 2023 $EQX
Equinox Gold
Comp. Grant Buy 17,285 63
Jan 03, 2023 $EQX
Equinox Gold
Other Buy 3,137 63
Dec 31, 2022 $ERO
Ero Copper
Comp. Grant Buy 835 38
Oct 31, 2022 $EQX
Equinox Gold
Exercise Sell 585 63
Oct 31, 2022 $EQX
Equinox Gold
Open Market Buy 315 $4.58 $1K 63
Oct 31, 2022 $EQX
Equinox Gold
Exercise Buy 585 $4.62 $3K 63
Oct 03, 2022 $EQX
Equinox Gold
Other Buy 3,208 $4.60 $15K 63
Sep 30, 2022 $ERO
Ero Copper
Comp. Grant Buy 1,125 38
Jun 30, 2022 $ERO
Ero Copper
Comp. Grant Buy 1,265 38
Mar 31, 2022 $ERO
Ero Copper
Comp. Grant Buy 799 38
Jan 20, 2022 $EQX
Equinox Gold
Comp. Grant Buy 9,466 63
Jan 19, 2022 $EQX
Equinox Gold
Open Market Buy 1,578 $9.16 $14K 63
Jan 15, 2022 $EQX
Equinox Gold
Exercise Buy 3,147 63
Jan 15, 2022 $EQX
Equinox Gold
Exercise Sell 3,147 63
Jan 04, 2022 $EQX
Equinox Gold
Other Buy 1,422 63
Dec 31, 2021 $ERO
Ero Copper
Comp. Grant Buy 582 38
Apr 07, 2021 $EQX
Equinox Gold
Corp. Event Sell 2,000 63
Apr 07, 2021 $EQX
Equinox Gold
Corp. Event Buy 2,000 $10.00 $20K 63
Dec 31, 2020 $ERO
Ero Copper
Comp. Grant Buy 553 38
Dec 17, 2020 $ERO
Ero Copper
Comp. Grant Buy 4,677 38
Dec 17, 2020 $ERO
Ero Copper
Comp. Grant Buy 3,601 $18.90 $68K 38
Oct 31, 2020 $EQX
Equinox Gold
Comp. Grant Buy 1,170 63
Sep 30, 2020 $ERO
Ero Copper
Comp. Grant Buy 636 38
Jan 02, 2020 $ERO
Ero Copper
Comp. Grant Buy 6,208 $23.42 $145K 38
Jan 02, 2020 $ERO
Ero Copper
Comp. Grant Buy 3,382 38
Muted rows are plan purchases, compensation grants, or DRIP — not open-market. Confluence Scores reflect the company's current score, not the score at time of trade.
Form55 provides data and analysis for informational purposes only. Nothing on this site constitutes investment advice or a recommendation to buy or sell any security. Past performance is not indicative of future results.